Zobrazeno 1 - 10
of 216
pro vyhledávání: '"метотрексат"'
Autor:
G. I. Gridneva, Yu. V. Muravyov, S. I. Glukhova, E. S. Aronova, E. Yu. Samarkina, N. V. Baimeeva
Publikováno v:
Современная ревматология, Vol 16, Iss 4, Pp 15-20 (2022)
The development of therapeutic drug monitoring of methotrexate (MT) remains an important and unresolved problem.Objective: to study the dynamics of the concentration of MT metabolites in groups of patients with different responses to MT therapy, to i
Externí odkaz:
https://doaj.org/article/16efaf6c9101418dae55f8176e95260b
Autor:
Yu. V. Muraviev, G. I. Gridneva
Publikováno v:
Безопасность и риск фармакотерапии, Vol 0, Iss 1, Pp 27-30 (2022)
This article describes herpes zoster (HZ) manifestation in RA patient treated with Methotrexate (MTX). The possibility of effective continuation of MTX after the symptoms of HZ resolve is demonstrated. The possibility of a causal relationship between
Externí odkaz:
https://doaj.org/article/4cb2ebcfe7bf4dce96e3c183a60a34d7
Autor:
I. T. Murkamilov, I. S. Sabirov, V. V. Fomin, Zh. A. Murkamilova, I. O. Kudaibergenova, F. A. Yusupov
Publikováno v:
Архивъ внутренней медицины, Vol 12, Iss 2, Pp 104-112 (2022)
Chronic kidney disease is a risk factor for other organ disease. People with kidney disease have an increased risk of developing and dying from cardiovascular disease, and there is also evidence that the risk of cancer and cancer mortality may be inc
Externí odkaz:
https://doaj.org/article/c7d706cb9e68415c9352f9b3cf3ff894
Autor:
A. V. Martynova, T. V. Popkova, A. P. Aleksankin, G. I. Gridneva, E. V. Gerasimova, Yu. N. Gorbunova, A. M. Lila
Publikováno v:
Современная ревматология, Vol 16, Iss 1, Pp 38-45 (2022)
Objective: assessment of the dynamics of T- and B-lymphocytes subpopulations in rheumatoid arthritis (RA) during therapy with synthetic disease-modifying antirheumatic drugs (sDMARDs) and biological disease-modifying antirheumatic drugs (bDMARDs): in
Externí odkaz:
https://doaj.org/article/17ef735ea5fa4fdd81c88ecfb2655910
Publikováno v:
Современная ревматология, Vol 16, Iss 1, Pp 46-51 (2022)
Objective: to search for an association between basal expression of the AMP-activated protein kinase (adenosine monophosphate-activated protein kinase, AMPK) gene in the blood of patients with rheumatoid arthritis (RA) and disease activity, as well a
Externí odkaz:
https://doaj.org/article/f1a8e30906794c20891029aab43e7675
Autor:
V. V. Lyalina, S. V. Borisovskaya, E. A. Skripnichenko, O. A. Ettinger, T. M. Padzheva, I. G. Nikitin
Publikováno v:
Архивъ внутренней медицины, Vol 12, Iss 1, Pp 22-34 (2022)
The rheumatic patients are characterized by various structural and functional changes, caused by chronic disease the necessity of constant medication intake, including anti-inflammatory drugs and immunosuppressants. In this regard, the rheumatic pati
Externí odkaz:
https://doaj.org/article/0e1be9fae8f44e389ca7a6bfdc591397
Autor:
M. S. Eliseev, E. V. Cheremushkina, O. V. Zhelyabina, M. N. Chikina, A. A. Kapitonova, A. A. Novikova, E. I. Markelova, A. M. Lila
Publikováno v:
Современная ревматология, Vol 15, Iss 6, Pp 76-83 (2021)
Anti-inflammatory therapy, such as colchicine (COL), has been suggested to affect the incidence of cardiovascular events in patients with calcium pyrophosphate crystal deposition disease (CPPD).Objective: to study the effect of anti-inflammatory ther
Externí odkaz:
https://doaj.org/article/75865715cca74821aab5e5f96695cf4d
Publikováno v:
Современная ревматология, Vol 15, Iss 3, Pp 15-19 (2021)
Clinical response to methotrexate (MT) therapy in rheumatoid arthritis (RA) can be predicted on the basis of some single nucleotide polymorphisms (SNPs) of genes, involved in folate metabolism. One of these SNPs is the rs1801394 (A66G) polymorphism o
Externí odkaz:
https://doaj.org/article/4c6b46b43cdf4687afb71665546ccb8c
Autor:
I. M. Marusenko, O. N. Sakovich
Publikováno v:
Современная ревматология, Vol 15, Iss 3, Pp 86-90 (2021)
The article describes the peculiarities of drug provision for patients with psoriatic arthritis (PsA) in the Republic of Karelia. We present a clinical case of effective treatment with interleukin 17 inhibitor ixekizumab (IXE) in a randomized clinica
Externí odkaz:
https://doaj.org/article/b40a9ecaae8c4bb1aa763abd42e63332
Autor:
A. V. Martynova, T. V. Popkova, A. P. Aleksankin, G. I. Gridneva, E. V. Gerasimova, Yu. N. Gorbunova, A. S. Semashko, A. M. Lila
Publikováno v:
Современная ревматология, Vol 15, Iss 2, Pp 17-22 (2021)
Objective: to evaluate changes in T- and B-lymphocyte subpopulations at different stages of rheumatoid arthritis (RA).Patients and methods. The study included 53 patients with a definite RA diagnosis according to the 2010 ACR/EULAR criteria (mean age
Externí odkaz:
https://doaj.org/article/f16451cc9d3447f5aab95e789336a9f3